Literature DB >> 8378600

Macrophage-directed tumour immunotherapy revisited--past and future of an old doctor's dilemma.

R Andreesen1.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8378600     DOI： 10.1016/0923-2494(93)80111-b

Source DB:  PubMed          Journal:  Res Immunol        ISSN： 0923-2494


× No keyword cloud information.
  2 in total

1.  Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors.

Authors:  Hideyuki Nakashima; Kotaro Miyake; Christopher R Clark; Joseph Bekisz; Joel Finbloom; Syed R Husain; Samuel Baron; Raj K Puri; Kathryn C Zoon
Journal:  Cancer Immunol Immunother       Date:  2011-12-13       Impact factor: 6.968

2.  A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancer.

Authors:  Daniel S Green; Ana T Nunes; Virginia David-Ocampo; Irene B Ekwede; Nicole D Houston; Steven L Highfill; Hanh Khuu; David F Stroncek; Seth M Steinberg; Kathryn C Zoon; Christina M Annunziata
Journal:  J Transl Med       Date:  2018-07-16       Impact factor: 5.531
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.